Lithium ion (Li+)

Lithium ion (Li+) is an inorganic alkali metal cation that serves as a crucial therapeutic agent, primarily recognized for its role as a mood stabilizer in psychiatric disorders. While not a classical receptor or enzyme, it exerts its effects by modulating numerous biological pathways and interacting with various cellular components. Its complex mechanism involves altering sodium transport, influencing neurotransmitter metabolism (like serotonin and catecholamines), and inhibiting key enzymes such as inositol monophosphatase (IMPase) and glycogen synthase kinase-3 (GSK-3). These actions collectively impact neuronal signaling, gene expression, and cellular resilience. Beyond its established use in bipolar disorder, lithium ion is being investigated for potential roles in neurodegenerative diseases like Alzheimer's and Parkinson's, acute brain injuries, and even as an adjunctive therapy in cancer. However, its therapeutic utility is challenged by a narrow therapeutic window, necessitating careful monitoring of serum levels to prevent toxicity. Adverse effects can impact renal, thyroid, cardiac, and neurological systems, highlighting the importance of patient selection and ongoing safety assessments.

Other names

Lithium cationLithium(1+)

Lithium ion's mechanism of action is complex and not fully understood, involving multiple cellular pathways. It modifies sodium transport in nerve and muscle cells and alters the metabolism of neurotransmitters such as catecholamines and serotonin. Lithium inhibits key enzymes like inositol monophosphatase (IMPase) and glycogen synthase kinase-3 (GSK-3), thereby affecting second messenger systems, including the phosphatidylinositol pathway. It can also influence cyclic AMP and NaK ATPases. Due to its small ionic radius, lithium can displace other physiologically important cations like sodium, potassium, and magnesium, interfering with their normal biological functions and enzyme activities.